Clinical Trial

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Recruiting
View on ClinicalTrials.gov →
Summary
A low plasma level of mannose binding lectin (p-MBL) is associated with unexplained recurrent pregnancy loss (RPL), but it is not investigated if it is associated with unexplained reproductive failure in general, including recurrent implantation failure (RIF) after assisted reproductive technology (ART) (including IVF, ICSI and FET), recurrent pregnancy loss (RPL) after spontaneous conception, and RPL after ART.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-12-19; most recent amendment 2025-11-20.
Status change: Not Yet Recruiting → Recruiting 2022-02-02
Trial Details
NCT Number NCT05169541
Lead Sponsor Aalborg University Hospital
Conditions Mannose-Binding Lectin Deficiency, Recurrent Pregnancy Loss, Recurrent Implantation Failure, Infertility, Habitual Abortion, Recurrent Miscarriage, Recurrent Spontaneous Abortion
Enrollment 500 participants
Start Date 2016-01-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-24